Drawing for PREVIFENON

USPTO serial 99528810

PREVIFENON

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ATTANG, UDEME U
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with PREVIFENON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angel Roman Campos

Angel Roman Campos MUNCY, GEISSLER, OLDS & LOWE, PC125 S. Royal StreetAlexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
005Contrast media for in vivo imaging; Sanitary panties; Pharmaceutical preparations for treating and prevention of respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of viral respiratory infectious diseases; Pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, namely, antibiotics; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of diseases and disorders of the immune system; Pharmaceutical products for the prevention and treatment of cognitive and intellectual deficit disorders, delays in psychomotor neurodevelopment, gestational disorders, hypertension, viral infections, sexually transmitted diseases, diseases caused by fungal infections, neoplasms and cancer; none of the foregoing relating to contraception or contraceptive productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Sep 8, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 11, 2026CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Aug 10, 2026APETASSIGNED TO PETITION STAFF—
Jul 29, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jul 6, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jun 10, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 19, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2026DOCKASSIGNED TO EXAMINER—
Dec 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance